|
1
|
Cervello M, McCubrey JA, Cusimano A,
Lampiasi N, Azzolina A and Montalto G: Targeted therapy for
hepatocellular carcinoma: Novel agents on the horizon. Oncotarget.
3:236–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schlesinger S, Aleksandrova K, Pischon T,
Fedirko V, Jenab M, Trepo E, Boffetta P, Dahm CC, Overvad K,
Tjønneland A, et al: Abdominal obesity, weight gain during
adulthood and risk of liver and biliary tract cancer in a European
cohort. Int J Cancer. 132:645–657. 2013. View Article : Google Scholar
|
|
4
|
Kretz M, Siprashvili Z, Chu C, Webster DE,
Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, et al:
Control of somatic tissue differentiation by the long non-coding
RNA TINCR. Nature. 493:231–235. 2013. View Article : Google Scholar :
|
|
5
|
Lagarde J, Uszczynska-Ratajczak B,
Carbonell S, Pérez-Lluch S, Abad A, Davis C, Gingeras TR, Frankish
A, Harrow J, Guigo R and Johnson R: High-throughput annotation of
full-length long noncoding RNAs with capture long-read sequencing.
Nat Genet. 49:1731–1740. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lagarde J, Uszczynska-Ratajczak B,
Santoyo-Lopez J, Gonzalez JM, Tapanari E, Mudge JM, Steward CA,
Wilming L, Tanzer A, Howald C, et al: Extension of human lncRNA
transcripts by RACE coupled with long-read high-throughput
sequencing (RACE-Seq). Nat Commun. 7:123392016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gatto S, Della Ragione F, Cimmino A,
Strazzullo M, Fabbri M, Mutarelli M, Ferraro L, Weisz A, D'Esposito
M and Matarazzo MR: Epigenetic alteration of microRNAs in
DNMT3B-mutated patients of ICF syndrome. Epigenetics. 5:427–443.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao X, Patton JR, Davis SL, Florence B,
Ames SJ and Spanjaard RA: Regulation of nuclear receptor activity
by a pseu-douridine synthase through posttranscriptional
modification of steroid receptor RNA activator. Mol Cell.
15:549–558. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu HR, Huang RZ, Yu XN, Shi X,
Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Dong L, Janssen HLA, et
al: Microarray expression profiling of microRNAs reveals potential
biomarkers for hepatocellular carcinoma. Tohoku J Exp Med.
245:89–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Subramanian A, Kuehn H, Gould J, Tamayo P
and Mesirov JP: GSEA-P: A desktop application for Gene Set
Enrichment Analysis. Bioinformatics. 23:3251–3253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soto JL, Cabrera CM, Serrano S and
López-Nevot MA: Mutation analysis of genes that control the G1/S
cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B. BMC
Cancer. 5:362005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moldovan GL, Pfander B and Jentsch S: PCNA
controls establishment of sister chromatid cohesion during S phase.
Mol Cell. 23:723–732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hess GF, Drong RF, Weiland KL, Slightom
JL, Sclafani RA and Hollingsworth RE: A human homolog of the yeast
CDC7 gene is overexpressed in some tumors and transformed cell
lines. Gene. 211:133–140. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang H, Hu M, Zhao R, Li P and Li M:
Dihydromyricetin suppresses the proliferation of hepatocellular
carcinoma cells by inducing G2/M arrest through the
Chk1/Chk2/Cdc25C pathway. Oncol Rep. 30:2467–2475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng P, Li Y, Yang L, Wen Y, Shi W, Mao
Y, Chen P, Lv H, Tang Q and Wei Y: Hepatitis B virus X protein
(HBx) induces G2/M arrest and apoptosis through sustained
activation of cyclin B1-CDK1 kinase. Oncol Rep. 22:1101–1107.
2009.PubMed/NCBI
|
|
22
|
Pellegrino R, Calvisi DF, Ladu S, Ehemann
V, Staniscia T, Evert M, Dombrowski F, Schirmacher P and Longerich
T: Oncogenic and tumor suppressive roles of polo-like kinases in
human hepatocellular carcinoma. Hepatology. 51:857–868.
2010.PubMed/NCBI
|
|
23
|
Shen G, Jia H, Tai Q, Li Y and Chen D:
miR-106b downregulates adenomatous polyposis coli and promotes cell
proliferation in human hepatocellular carcinoma. Carcinogenesis.
34:211–219. 2013. View Article : Google Scholar
|
|
24
|
Chen X, Chen S, Xiu YL, Sun KX, Zong ZH
and Zhao Y: RhoC is a major target of microRNA-93-5P in epithelial
ovarian carcinoma tumorigenesis and progression. Mol Cancer.
14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Markopoulos GS, Roupakia E, Tokamani M,
Vartholomatos G, Tzavaras T, Hatziapostolou M, Fackelmayer FO,
Sandaltzopoulos R, Polytarchou C and Kolettas E:
Senescence-associated microRNAs target cell cycle regulatory genes
in normal human lung fibroblasts. Exp Gerontol. 96:110–122. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Q, Jia H, Li H, Dong C, Wang Y and Zou
Z: LncRNA and mRNA expression profiles of glioblastoma multiforme
(GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
Tumour Biol. 37:14537–14552. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang F, Gao C, Ma XF, Peng XL, Zhang RX,
Kong DX, Simard AR and Hao JW: Expression profile of long noncoding
RNAs in peripheral blood mononuclear cells from multiple sclerosis
patients. CNS Neurosci Ther. 22:298–305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar
|
|
29
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li D, Liu X, Zhou J, Hu J, Zhang D, Liu J,
Qiao Y and Zhan Q: Long noncoding RNA HULC modulates the
phosphorylation of YB-1 through serving as a scaffold of
extracellular signal-regulated kinase and YB-1 to enhance
hepatocarcinogenesis. Hepatology. 65:1612–1627. 2017. View Article : Google Scholar
|
|
31
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar
|
|
32
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
over-expression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar
|
|
33
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dai L, Li J, Xing M, Sanchez TW, Casiano
CA and Zhang JY: Using serological proteome analysis to identify
serum anti-nucleophosmin 1 autoantibody as a potential biomarker in
European-American and African-American patients with prostate
cancer. Prostate. 76:1375–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jo SY, Park SH, Kim IS, Yi J, Kim HH,
Chang CL, Lee EY, Cho YU, Jang S, Park CJ and Chi HS: Correlation
of NPM1 type A mutation burden with clinical status and outcomes in
acute myeloid leukemia patients with mutated NPM1 type A. Ann Lab
Med. 36:399–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Versluis J, In 't Hout FE, Devillier R,
van Putten WL, Manz MG, Vekemans MC, Legdeur MC, Passweg JR,
Maertens J, Kuball J, et al: Comparative value of post-remission
treatment in cytoge-netically normal AML subclassified by NPM1 and
FLT3-ITD allelic ratio. Leukemia. 31:26–33. 2017. View Article : Google Scholar
|
|
37
|
Wong JC, Hasan MR, Rahman M, Yu AC, Chan
SK, Schaeffer DF, Kennecke HF, Lim HJ, Owen D and Tai IT:
Nucleophosmin 1, upreg-ulated in adenomas and cancers of the colon,
inhibits p53-mediated cellular senescence. Int J Cancer.
133:1567–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang HD, Kim PJ, Eun JW, Shen Q, Kim HS,
Shin WC, Ahn YM, Park WS, Lee JY and Nam SW: Oncogenic potential of
histone-variant H2A.Z.1 and its regulatory role in cell cycle and
epithelial-mesenchymal transition in liver cancer. Oncotarget.
7:11412–11423. 2016.PubMed/NCBI
|
|
39
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudo-gene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nault JC, Datta S, Imbeaud S, Franconi A,
Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, et al:
Recurrent AAV2-related insertional mutagenesis in human
hepatocellular carcinomas. Nat Genet. 47:1187–1193. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou YM, Zhang XF, Cao L, Li B, Sui CJ, Li
YM and Yin ZF: MCM7 expression predicts post-operative prognosis
for hepato-cellular carcinoma. Liver Int. 32:1505–1509. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016.
View Article : Google Scholar : PubMed/NCBI
|
